Skip to main content
Clinical Trials/CTRI/2014/03/004491
CTRI/2014/03/004491Recruiting未知

Efficacy and safety of 400 microgram misoprostol by sublingual route to augment routine management of third stage of labour in high risk women following vaginal delivery.

RS MEDICAL COLLEGE KOLKATA0 sites200 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Women with one or more of the high risk factors as
  • multiple pregnancy
  • polyhydramnios
  • prolonged labour
  • labor augmented by oxytocin.
  • H/O PPH in previous pregnancy.
  • Post caesarean section (for vaginal delivery)
  • Obese patient (BMJ >30)
  • Grand multipara
  • Severe preeclampsia/eclampsia.
  • Anaemia(hb <10gm%)

Exclusion Criteria

  • Any contraindications for the use of misoprostol and oxytocin such as known hypersensitivity, asthma, epilepsy etc.
  • Cardiovascular, hepatic, haematological disorders.
  • Temperature >38ï?°C

Investigators

Sponsor
RS MEDICAL COLLEGE KOLKATA

Similar Trials